The Bridge

The following article from the Milken Institute serves as a roadmap for this new landscape. It moves past the emotional plea and dives into the hard logic of why rare disease research is one of the most sophisticated and rewarding frontiers for modern investors and donors. By viewing these 10,000 conditions not as isolated burdens, but as a collective 'innovation engine,' we can see the massive potential for both societal impact and scientific ROI. Let’s explore how the 'rare' is actually the key to unlocking health for everyone."

Link to Milken Institute Five Reasons Why Philanthropists Should Invest in Rare Disease Research